Tg Therapeutics reported $71.13M in Loan Capital for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Amgen AMGN:US USD 37.35B 193M
Bayer BAYN:GR EUR 33.79B 5.67B
Biogen BIIB:US USD 6.28B 1.8M
Dynavax Technologies DVAX:US USD 221.58M 275K
Intercept Pharmaceuticals ICPT:US USD 223.1M 248K
Karyopharm Therapeutics KPTI:US USD 302.82M 69K
Novartis NOVN:VX USD 21.78B 547M
Novavax NVAX:US USD 197.7M 166.23M
Ptc Therapeutics PTCT:US USD 1.28B 294.53M
Puma Biotechnology PBYI:US USD 98.31M 313K
Regeneron Pharmaceuticals REGN:US USD 2.7B 300K
Roche Holding ROG:VX 21.39B 978M
Tg Therapeutics TGTX:US USD 71.13M 1.1M
Verastem VSTM:US USD 24.53M 141K
Vertex Pharmaceuticals VRTX:US USD 471.6M 29.3M